Human β-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity

PloS One
Himanshu Sharma, Ramakrishnan Nagaraj

Abstract

Human defensins play multiple roles in innate immunity including direct antimicrobial killing and immunomodulatory activity. They have three disulfide bridges which contribute to the stability of three anti-parallel β-strands. The exact role of disulfide bridges and canonical β-structure in the antimicrobial action is not yet fully understood. In this study, we have explored the antimicrobial activity of human β-defensin 4 (HBD4) analogs that differ in the number and connectivity of disulfide bridges. The cysteine framework was similar to the disulfide bridges present in μ-conotoxins, an unrelated class of peptide toxins. All the analogs possessed enhanced antimicrobial potency as compared to native HBD4. Among the analogs, the single disulfide bridged peptide showed maximum potency. However, there were no marked differences in the secondary structure of the analogs. Subtle variations were observed in the localization and membrane interaction of the analogs with bacteria and Candida albicans, suggesting a role for disulfide bridges in modulating their antimicrobial action. All analogs accumulated in the cytosol where they can bind to anionic molecules such as nucleic acids which would affect several cellular processes leading t...Continue Reading

References

Jan 30, 1991·Biochimica Et Biophysica Acta·R C MacDonaldL R Hu
Jul 16, 1991·Biochemistry·J M LancelinF Inagaki
Aug 1, 1989·The Journal of Clinical Investigation·R I LehrerM E Selsted
Sep 1, 1994·Protein Science : a Publication of the Protein Society·W C WimleyS H White
Jan 1, 1993·Annual Review of Immunology·R I LehrerT Ganz
Aug 1, 1995·Current Opinion in Structural Biology·S H WhiteM E Selsted
Jun 26, 1997·Nature·J HarderJ M Schröder
Mar 12, 1998·FEMS Microbiology Letters·C Subbalakshmi, N Sitaram
Jan 1, 1999·Bioorganic & Medicinal Chemistry Letters·P J WeberA G Beck-Sickinger
Jan 27, 1999·Biochemical and Biophysical Research Communications·S Thennarasu, R Nagaraj
Jun 26, 1999·Molecular Microbiology·I Fishov, C L Woldringh
Jul 25, 2000·The Journal of Biological Chemistry·D M HooverJ Lubkowski
Nov 22, 2000·The Journal of Biological Chemistry·J HarderJ M Schroder
Jul 18, 2001·Journal of the American Chemical Society·A G CochranN J Skelton
Aug 4, 2001·The Journal of Biological Chemistry·D M HooverJ Lubkowski
May 3, 2002·The Journal of Peptide Research : Official Journal of the American Peptide Society·M Mandal, R Nagaraj
May 15, 2002·The Journal of Biological Chemistry·Katherine J NielsenRichard J Lewis
Jun 11, 2002·Biochemical and Biophysical Research Communications·Raffaella CircoMargherita Zanetti
Dec 20, 2002·Biopolymers·Yechiel Shai
Jul 4, 2003·Proceedings of the National Academy of Sciences of the United States of America·Zhibin WuWuyuan Lu
Aug 26, 2003·Antimicrobial Agents and Chemotherapy·David M HooverJacek Lubkowski
Sep 2, 2003·Nature Reviews. Immunology·Tomas Ganz
Dec 26, 2003·Biophysical Journal·Reiko IshitsukaToshihide Kobayashi
Jan 13, 2004·Physiological Reviews·Heinrich Terlau, Baldomero M Olivera
Aug 7, 2004·The Journal of Biological Chemistry·Atsuo MaemotoAndre J Ouellette
Nov 24, 2004·Biophysical Journal·Krzysztof MurzynMarta Pasenkiewicz-Gierula
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·Bryan EricksenRobert I Lehrer
Dec 25, 2004·Journal of Leukocyte Biology·Jan WehkampEduard F Stange
Feb 11, 2005·Nature Reviews. Microbiology·Kim A Brogden
Apr 12, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Josef Johann SchneiderHans Christian Korting
May 17, 2005·The Journal of Biological Chemistry·Cao XieWuyuan Lu
May 24, 2005·Nature Immunology·Michael E Selsted, Andre J Ouellette
Jan 27, 2006·Applied Microbiology and Biotechnology·Zhinan XuPeilin Cen
Apr 26, 2006·Biochemistry·Arne BöhlingThomas Gutsmann
May 20, 2006·Cellular and Molecular Life Sciences : CMLS·M PazgierJ Lubkowski
Sep 6, 2006·Toxicon : Official Journal of the International Society on Toxinology·Raymond S Norton, Baldomero M Olivera

❮ Previous
Next ❯

Citations

Nov 26, 2015·Cytokine & Growth Factor Reviews·Ehab H MattarElrashdy M Redwan
Jul 13, 2017·Chemical Reviews·Deborah Fass, Colin Thorpe
Nov 15, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chunlan XuMingliang Jin
Dec 2, 2017·Journal of Peptide Science : an Official Publication of the European Peptide Society·A S VasilchenkoM V Sycheva
Feb 20, 2019·Frontiers in Chemistry·Evan F HaneyRobert E W Hancock
Oct 18, 2020·The Protein Journal·Ritika Kabra, Shailza Singh
May 13, 2021·Journal, Genetic Engineering & Biotechnology·S NeelimaRosamma Philip
Jun 3, 2021·Pharmaceuticals·Malak PirtskhalavaGrigol Managadze

❮ Previous
Next ❯

Methods Mentioned

BETA
dynamic light scattering
confocal microscopy
X-ray
NMR
by nuclear magnetic

Software Mentioned

LAS
ImageJ
AF

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

Journal of Peptide Science : an Official Publication of the European Peptide Society
Himanshu SharmaRamakrishnan Nagaraj
Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology
Simon JägerEduard F Stange
The Journal of Investigative Dermatology
Dong-Youn LeeRichard L Gallo
Biochemical Society Transactions
D J Clarke, Dominic J Campopiano
© 2021 Meta ULC. All rights reserved